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Summary Q fever has rarely been reported and can be difﬁcult to diagnose, espe-
cially in immunocompromised patients. In the present report, we describe an unusual
case of Q fever that presented as peritonitis and was treated with long-term com-
bination therapy with doxycycline, ciproﬂoxacin and rifampicin for ﬁve weeks in
a patient who had been on peritoneal dialysis for six years due to hypertensive
nephropathy.
© 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
Limited. All rights reserved.
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introductionfever is caused by Coxiella burnetii and is a
orldwide zoonotic disease. The primary reservoirs
f this intracellular, pleomorphic, Gram-negative
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876-0341/© 2015 King Saud Bin Abdulaziz University for Health Scieicroorganism are cattle, sheep and goats. The
nfected animals transmit the pathogen via bac-
erial shedding in their body secretions. Humans
ecome infected via the inhalation of infectious
erosols either directly from the secretions of
nfected animals or from dust contaminated with
hese ﬂuids [1,2].Q fever can be difﬁcult to diagnose due to its
onspeciﬁc clinical presentations. In this study, we
eport an unusual case of Q fever that presented as
eritonitis in a patient undergoing dialysis.
nces. Published by Elsevier Limited. All rights reserved.
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Case report
A 41-year-old man living in a village with sheep
and goats had been on peritoneal dialysis for six
years due to hypertensive nephropathy and expe-
rienced six attacks peritonitis within this period.
Previous peritoneal ﬂuid cultures yielded E. coli and
coagulase-negative staphylococci. He was admitted
to hospital with a 10-day history of fever, nau-
sea, vomiting and weakness. Only fever (39 ◦C)
and abdominal tenderness were noted on phys-
ical examination. Laboratory tests revealed an
elevated leukocyte count (17.3× 109/mm3), sedi-
mentation rate (75mm/h) and C-reactive protein
level (CRP, 9.5mg/L for normal values <3mg/L)
and anemia (with a hemoglobin level of 10.1 g/dL).
Blood biochemistry tests revealed liver cholestasis
(alkaline phosphatase (ALP) 161U/L, normal val-
ues <129U/L and gamma-glutamyl transpeptidase
(GGT) 65U/L, normal values <60U/L) and normal
transaminase and bilirubin levels. Renal function
tests revealed hyperazotemia (BUN 30mg/dL, nor-
mal values <20mg/dL and creatinine 13.2mg/dL,
normal values <1.2mg/dL).
A peritoneal ﬂuid examination revealed
170 cells/mm3, and the patient was given
tazobactam-piperacillin and vancomycin empiri-
cally with the preliminary diagnosis of peritonitis.
Because the patient remained febrile, the antibi-
otic treatment was switched to imipenem and
vancomycin. The blood and peritoneal ﬂuid cul-
tures were sterile. Due to the persistence of
fever, the peritoneal catheter was removed,
but no microorganisms were grown on culture.
Despite treatment with broad-spectrum antimi-
crobials that included colistin, daptomycin and
ﬂuconazole, the fever persisted. Gruber-Widal and
Wright tube agglutination tests, a viral hepatitis
panel (for hepatitis A, B and C) and serologies for
Epstein—Barr virus and cytomegalovirus were nega-
tive. Immunological tests indicated no autoimmune
disease but were consistent with mild hypergam-
maglobulinemia (IgG level 21.6 g/L, normal values
<16 g/L). Enzyme-linked immunosorbent assays
for antiphospholipid and anticardiolipin antibodies
were negative.
A computed tomography (CT) scan of the tho-
rax, abdomen and pelvis revealed bilateral minimal
pleural effusion, diffuse thickening of the rec-
tum, sigmoid colon and peritoneum and massive
ascites and peritonitis (Fig. 1). Gram and Ziehl-
Neelsen stainings and cultures, polymerase chain
reaction (PCR), cytology of the ascites ﬂuid and
a QuantiFERON test for tuberculosis were nega-
tive. Transesophageal echocardiography revealed
no lesions. A bone marrow biopsy was normal, and
r
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iigure 1 Abdominal CT scan showing diffuse thickening
f the peritoneum and as cite.
peritoneum biopsy revealed chronic inﬂamma-
ion.
Q fever was suggested due to the history of
nimal exposure, and a serological survey for Cox-
ella burnetii was performed. Although the Phase 1
gM-IgG and Phase 2 IgM titers were negative, the
hase 2 IgG was 1/1024 (Vircell SL, Spain). The tests
ere performed at the Reﬁk Saydam National Public
ealth Agency of the Ministry of Health. Subse-
uently, a combination treatment with doxycycline
nd ciproﬂoxacin was initiated. Because the patient
emained febrile on the 10th day of treatment,
ifampicin was added to the therapy. The patient
as afebrile on the ﬁfth day of triple antibiotic
herapy. After ﬁve weeks of therapy, his white blood
ell count and CRP were in the normal ranges, the
hase 2 IgG titer decreased to a titer of 1/256, and
he cell counts in the peritoneal ﬂuid and ascites
nd thickening of the peritoneum resolved.
iscussion
fever was ﬁrst described in 1937 by Derrick EQ.
otals of 1168 cases between 1948 and 1977 and 436
ases between 1978 and 1999 were reported to the
enters for Disease Control and Prevention (CDC).
ince 1999, Q fever has become a notiﬁable disease
n the United States due to its potential as a bio-
ogical warfare agent [1]. Since that time, reports
f Q fever have increased, and from 2007 to 2010,
he largest Q fever outbreak, which involved 4000
uman cases, was reported in the Netherlands [3].
In Turkey, the Coxiella burnetii IgG seropositivityates are 1.8—13.5% in healthy people and 42.4% in
igh-risk groups [4—6]. The factors that suggested
cute Q fever in our patient were the follow-
ng: a history of animal exposure, fever, headache,
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Rn unusual manifestation of Q fever
nemia, elevated sedimentation rate and CRP
evel, and hypergammaglobulinemia. Despite nor-
al transaminase and biluribin levels, the patient
xhibited elevated ALP and GGT levels that were
imilar to those reported in a study from France
7]. The ﬁndings that were not consistent with Q
ever were the following: the absence of thrombo-
ytopenia, and the normal levels of anticardiolipin
nd antiphospholipid antibodies. In a recent report
rom the CDC, thrombocytopenia was reported in
5% and antiphospholipid antibodies were detected
n 50% of cases [2].
The spectrum of Q fever is pleomorphic, the
ajor clinical presentations include acute febrile
llness, pneumonia and hepatitis, and the disease
as rarely been reported in immunocompromised
osts [1,8—10]. In a review from France, 20%
f 84 chronic Q fever patients were immuno-
uppressed, including patients with cancer, renal
ransplantation, chronic myeloid leukemia, cor-
icosteroid therapy, acquired immunodeﬁciency
yndrome, postpartum status, chronic alcoholism
nd renal dialysis [11]. Our patient had been on
eritoneal dialysis for six years. The absolute num-
ers of T cells in patients who have received dialysis
or more than one year are reduced [12]. Fur-
hermore, long-term exposure of peritoneal cells
o dialysis solutions might also alter the normal
mmunological reactions against bacteria (e.g.,
ecreased opsonic activities against bacteria) [13].
ecause the immune control of C. burnetii is T-cell
ependent, patients on renal dialysis are prone to
ntracellular bacteria such as C. burnetii [14].
Pericarditis, myocarditis, thyroiditis, menin-
oencephalitis, hemolytic anemia, nephritis,
steomyelitis and hemophagocytic syndrome are
are manifestations of Q fever [7,15,16]. In addi-
ion to the knowledge provided by our case, Chang
t al. described peritonitis as a manifestation of Q
ever in a patient with diabetes mellitus in Taiwan
17]. These authors observed peritoneal involve-
ent on a gallium scan and diffuse abdominal
ptake on an inﬂammatory scan.
We were unable to isolate the bacteria, and the
eritoneal ﬂuid PCR was negative because it was
erformed long after the onset of the symptoms.
he diagnosis of the patient was conﬁrmed by an
ndirect immunoﬂuorescence (IF) test. In suspected
ases, the diagnosis of Q fever should be conﬁrmed
y serum titers (IgG and/or IgM) obtained via IF
ecause these tests are very sensitive and speciﬁc
18]. The diagnosis of Q fever was based on the pos-
tivity of the Phase 2 IgG (1/1024). Concordant with
he cases reported by Yes¸ilyurt et al., the Phase 2
gM was negative [19]. We believe that this nega-
ivity resulted from the suppression of the immune
[375
ystem due to chronic renal failure. Because of the
oor responsiveness of the patient to doxycycline
nd ciproﬂoxacin therapy, rifampicin was added to
he therapy. He recovered after 5 weeks of triple
ntibiotic therapy. The inﬂammatory markers in the
erum, cell counts in the peritoneal ﬂuid and ascites
nd the thickening of the peritoneum were resolved
fter this therapy. Long-duration combination ther-
py should be considered for certain patients who
xhibit poor responsiveness to monotherapy, par-
icularly immunocompromised patients.
We reported an unusual case of Q fever that pre-
ented as peritonitis. Clinicians should be aware
f such rare manifestations, particularly immuno-
ompromised patients, because the infrequent
onsideration of Q fever in such patients could
elay therapy.
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